文献速递心境障碍

难治性抑郁症的全基因组关联研究:与代谢特征的共享生物学

Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.
PubMed 文献 · Am J Psychiatry · 2024-05-15

该研究以接受电休克治疗(ECT)作为难治性抑郁症(TRD)的替代指标,利用机器学习从电子健康记录中推导ECT预测概率,并在四个大型生物库的154,433名基因分型患者中作为数量性状进行全基因组关联研究。结果显示遗传率估计为2%至4.2%,发现两个全基因组显著位点均与代谢特征相关,并观察到与认知、注意缺陷多动障碍、精神分裂症、酒精与吸烟特征及体重指数的显著遗传重叠。

要点

  • 以ECT接收作为TRD替代指标,在154,433名患者中开展全基因组关联研究。
  • TRD遗传率估计为2%至4.2%,与代谢、认知、精神分裂症等特征存在遗传重叠。
  • 发现两个全基因组显著位点,均先前与代谢特征相关,提示共享生物学。

核心结论

  • 该工作支持利用疾病概率估计进行基因组研究,并为难治性抑郁症的遗传结构和生物学提供了见解。

研究设计与样本

  • 研究应用标准机器学习方法于电子健康记录数据,推导接受电休克治疗的预测概率作为难治性抑郁症的替代指标。
  • 将预测概率作为数量性状,在四个大型生物库的154,433名基因分型患者中进行全基因组关联研究。

主要发现

  • 遗传率估计范围为2%至4.2%。
  • 观察到与认知、注意缺陷多动障碍、精神分裂症、酒精和吸烟特征以及体重指数的显著遗传重叠。
  • 识别出两个全基因组显著位点,均先前与代谢特征相关。

关键数值与推荐

  • 难治性抑郁症在重性抑郁障碍个体中约占三分之一。
  • 与未治疗抵抗的重性抑郁障碍相比,难治性抑郁症的遗传率估计为8%。

临床怎么用

  • 研究提示难治性抑郁症与代谢特征存在共享生物学,可能具有药理学意义。
  • 利用电子健康记录推导的疾病概率可作为基因组研究的性状,支持难治性抑郁症的遗传研究。

局限性

  • 以接受电休克治疗作为难治性抑郁症的替代指标,可能不完全代表所有难治性抑郁症患者。
  • 研究指出此前缺乏足够效能的队列来研究该表型,且尚无复制的遗传位点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Treatment-resistant depression (TRD) occurs in roughly one-third of all individuals with major depressive disorder (MDD). Although research has suggested a significant common variant genetic component of liability to TRD, with heritability estimated at 8% when compared with non-treatment-resistant MDD, no replicated genetic loci have been identified, and the genetic architecture of TRD remains unclear. A key barrier to this work has been the paucity of adequately powered cohorts for investigation, largely because of the challenge in prospectively investigating this phenotype. The objective of this study was to perform a well-powered genetic study of TRD. METHODS: Using receipt of electroconvulsive therapy (ECT) as a surrogate for TRD, the authors applied standard machine learning methods to electronic health record data to derive predicted probabilities of receiving ECT. These probabilities were then applied as a quantitative trait in a genome-wide association study of 154,433 genotyped patients across four large biobanks. RESULTS: Heritability estimates ranged from 2% to 4.2%, and significant genetic overlap was observed with cognition, attention deficit hyperactivity disorder, schizophrenia, alcohol and smoking traits, and body mass index. Two genome-wide significant loci were identified, both previously implicated in metabolic traits, suggesting shared biology and potential pharmacological implications. CONCLUSIONS: This work provides support for the utility of estimation of disease probability for genomic investigation and provides insights into the genetic architecture and biology of TRD.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kang J, Castro VM, Ripperger M, et al. Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits. Am J Psychiatry. 2024. PMID: 38745458. doi:10.1176/appi.ajp.20230247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。